A road map for efficient and reliable human genome epidemiology.

PubWeight™: 3.21‹?› | Rank: Top 1%

🔗 View Article (PMID 16468121)

Published in Nat Genet on January 01, 2006

Authors

John P A Ioannidis1, Marta Gwinn, Julian Little, Julian P T Higgins, Jonine L Bernstein, Paolo Boffetta, Melissa Bondy, Molly S Bray, Paul E Brenchley, Patricia A Buffler, Juan Pablo Casas, Anand Chokkalingam, John Danesh, George Davey Smith, Siobhan Dolan, Ross Duncan, Nelleke A Gruis, Patricia Hartge, Mia Hashibe, David J Hunter, Marjo-Riitta Jarvelin, Beatrice Malmer, Demetrius M Maraganore, Julia A Newton-Bishop, Thomas R O'Brien, Gloria Petersen, Elio Riboli, Georgia Salanti, Daniela Seminara, Liam Smeeth, Emanuela Taioli, Nic Timpson, Andre G Uitterlinden, Paolo Vineis, Nick Wareham, Deborah M Winn, Ron Zimmern, Muin J Khoury, Human Genome Epidemiology Network and the Network of Investigator Networks

Author Affiliations

1: Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, and Biomedical Research Institute, Foundation for Research and Technology-Hellas, Ioannina 45110, Greece. jioannid@cc.uoi.gr

Articles citing this

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46

Prioritizing GWAS results: A review of statistical methods and recommendations for their application. Am J Hum Genet (2010) 5.39

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ (2007) 5.38

Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol (2008) 4.53

Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet (2007) 3.92

The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44

The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26

Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol (2011) 2.85

STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39

Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39

Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol (2009) 2.15

STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82

Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies. Eur J Hum Genet (2010) 1.79

GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique. BMC Bioinformatics (2008) 1.75

Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies. Eur J Hum Genet (2011) 1.69

Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation. Prostate (2010) 1.67

A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research. Eur J Epidemiol (2010) 1.66

Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med (2009) 1.60

Genotype-phenotype databases: challenges and solutions for the post-genomic era. Nat Rev Genet (2009) 1.52

International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev (2008) 1.51

Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47

Bayesian meta-analysis of genetic association studies with different sets of markers. Am J Hum Genet (2008) 1.44

Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies. PLoS One (2009) 1.43

Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med (2007) 1.38

The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet (2009) 1.35

Genome scanning by composite likelihood. Am J Hum Genet (2006) 1.28

Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol (2009) 1.25

An open source infrastructure for managing knowledge and finding potential collaborators in a domain-specific subset of PubMed, with an example from human genome epidemiology. BMC Bioinformatics (2007) 1.24

Reporting of human genome epidemiology (HuGE) association studies: an empirical assessment. BMC Med Res Methodol (2008) 1.17

Family-based versus unrelated case-control designs for genetic associations. PLoS Genet (2006) 1.15

Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation. Eur J Epidemiol (2008) 1.14

Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer's disease. Am J Epidemiol (2008) 1.13

An automatic method to generate domain-specific investigator networks using PubMed abstracts. BMC Med Inform Decis Mak (2007) 1.11

The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults. PLoS One (2008) 0.98

A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes. Eur J Hum Genet (2013) 0.98

Expectations, validity, and reality in pharmacogenetics. J Clin Epidemiol (2009) 0.96

Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues. JRSM Cardiovasc Dis (2012) 0.93

Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction. BMC Genomics (2011) 0.91

Online genetic databases informing human genome epidemiology. BMC Med Res Methodol (2007) 0.91

TPH2 gene polymorphisms and major depression--a meta-analysis. PLoS One (2012) 0.91

Angiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of small-study bias. PLoS Med (2006) 0.91

MDPD: an integrated genetic information resource for Parkinson's disease. Nucleic Acids Res (2008) 0.88

High-throughput genomic technology in research and clinical management of breast cancer. Evolving landscape of genetic epidemiological studies. Breast Cancer Res (2006) 0.86

Reporting of systematic reviews: the challenge of genetic association studies. PLoS Med (2007) 0.85

Genetic and molecular epidemiology. J Epidemiol Community Health (2007) 0.84

Heterogeneity-based genome search meta-analysis for preeclampsia. Hum Genet (2006) 0.82

Harnessing Nutrigenomics: Development of web-based communication, databases, resources, and tools. Genes Nutr (2006) 0.80

CER1 gene variations associated with bone mineral density, bone markers, and early menopause in postmenopausal women. Hum Genomics (2013) 0.80

Antipsychotic-induced movement disorders in long-stay psychiatric patients and 45 tag SNPs in 7 candidate genes: a prospective study. PLoS One (2012) 0.78

Assessment of systematic effects of methodological characteristics on candidate genetic associations. Hum Genet (2012) 0.77

Cancer genetic association studies in the genome-wide age. Per Med (2008) 0.75

Genetic association studies in cancer: good, bad or no longer ugly? Hum Genomics (2006) 0.75

The latest news from the GENOMOS study. Clin Cases Miner Bone Metab (2009) 0.75

Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism Impacts on Migraine Susceptibility: A Meta-analysis of Case-Control Studies. Front Neurol (2017) 0.75

Articles by these authors

Finding the missing heritability of complex diseases. Nature (2009) 67.95

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88

Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet (2008) 30.94

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet (2008) 16.25

Replicating genotype-phenotype associations. Nature (2007) 16.11

A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature (2008) 16.10

Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet (2009) 14.52

Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med (2014) 12.79

Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med (2007) 12.55

Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet (2008) 12.32

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med (2002) 10.78

Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol (2010) 10.70

Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58

Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet (2007) 9.88

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med (2007) 9.48

Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med (2008) 9.39

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13

Letting the genome out of the bottle--will we get our wish? N Engl J Med (2008) 9.10

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07

How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med (2011) 8.48

Incidental meniscal findings on knee MRI in middle-aged and elderly persons. N Engl J Med (2008) 8.40

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37

Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet (2013) 8.20

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

50-year trends in smoking-related mortality in the United States. N Engl J Med (2013) 7.80

Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol (2006) 7.66

Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

Serious mental disorder in 23000 prisoners: a systematic review of 62 surveys. Lancet (2002) 7.43

Genetic risk prediction--are we there yet? N Engl J Med (2009) 7.30

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30

Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol (2007) 7.00

Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet (2012) 6.97

Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet (2009) 6.91

Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med (2011) 6.89

Prevalence of serious mental disorder in 7000 refugees resettled in western countries: a systematic review. Lancet (2005) 6.88

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80

Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet (2008) 6.71

Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69

Powerful SNP-set analysis for case-control genome-wide association studies. Am J Hum Genet (2010) 6.60

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet (2005) 6.59

Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol (2005) 6.52

Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet (2013) 6.19

Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation (2006) 6.17

Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16

Hypertension in sub-saharan Africa: a systematic review. Hypertension (2007) 6.14

Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol (2013) 6.12